Clinical Trial Update: Autologous Bone Marrow Stem Cells in Ischemic Stroke. [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for autologous bone marrow stem cells in acute ischemic stroke (Phase 1/Phase 2) completed, conducted by Imperial College London.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infarction of the Middle Cerebral Artery
• Stroke

Drugs mentioned

• Autologous bone marrow stem cells (autologous bone marrow stem cells)

Snippet

Sponsor: Imperial College London | Conditions: Stroke, Acute, Infarction, Middle Cerebral Artery | Phase 1, Phase 2 | Status: COMPLETED